See more : Sony Group Corporation (6758.T) Income Statement Analysis – Financial Results
Complete financial analysis of Medimaging Integrated Solution Inc. (6796.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medimaging Integrated Solution Inc., a leading company in the Healthcare industry within the Healthcare sector.
- Investec Group (INL.JO) Income Statement Analysis – Financial Results
- New Pacific Metals Corp. (NUAG.TO) Income Statement Analysis – Financial Results
- Focus Impact Acquisition Corp. (FIACW) Income Statement Analysis – Financial Results
- U. Y. FINCORP LIMITED (UYFINCORP.BO) Income Statement Analysis – Financial Results
- Winto Group (Holdings) Limited (8238.HK) Income Statement Analysis – Financial Results
Medimaging Integrated Solution Inc. (6796.TW)
About Medimaging Integrated Solution Inc.
Medimaging Integrated Solution Inc. provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope, including optical coherence tomography, control unit scopes, software, and accessories; computing-based AI screening in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions, a micro camera module for visualization performance and provides patient-oriented care; and micro camera modules. Medimaging Integrated Solution Inc. was founded in 2010 and is headquartered in Hsinchu City, Taiwan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 537.15M | 502.09M | 485.87M | 402.47M | 0.00 |
Cost of Revenue | 229.39M | 247.70M | 230.15M | 183.20M | 0.00 |
Gross Profit | 307.76M | 254.39M | 255.72M | 219.28M | 0.00 |
Gross Profit Ratio | 57.30% | 50.67% | 52.63% | 54.48% | 0.00% |
Research & Development | 126.83M | 126.13M | 107.59M | 100.74M | 0.00 |
General & Administrative | 48.55M | 38.62M | 36.95M | 32.93M | 0.00 |
Selling & Marketing | 39.74M | 29.94M | 24.58M | 17.46M | 0.00 |
SG&A | 88.29M | 68.57M | 61.53M | 50.38M | 0.00 |
Other Expenses | 0.00 | 27.82M | -5.05M | -3.81M | 5.70M |
Operating Expenses | 215.84M | 194.70M | 169.12M | 151.13M | 5.70M |
Cost & Expenses | 445.23M | 442.40M | 399.27M | 334.32M | 5.70M |
Interest Income | 5.08M | 1.41M | 364.00K | 504.00K | 783.00K |
Interest Expense | 3.85M | 1.42M | 1.03M | 1.28M | 1.36M |
Depreciation & Amortization | 31.63M | 30.07M | 33.01M | 28.88M | 0.00 |
EBITDA | 119.38M | 118.98M | 114.93M | 93.72M | 5.70M |
EBITDA Ratio | 22.22% | 23.70% | 23.65% | 23.29% | 0.00% |
Operating Income | 91.92M | 88.92M | 81.92M | 64.84M | 5.70M |
Operating Income Ratio | 17.11% | 17.71% | 16.86% | 16.11% | 0.00% |
Total Other Income/Expenses | 1.06M | 27.81M | -5.69M | -4.59M | -656.00K |
Income Before Tax | 92.98M | 87.41M | 80.91M | 60.23M | 0.00 |
Income Before Tax Ratio | 17.31% | 17.41% | 16.65% | 14.97% | 0.00% |
Income Tax Expense | 18.93M | 17.39M | 14.43M | 6.11M | 0.00 |
Net Income | 74.05M | 70.02M | 66.48M | 54.12M | 0.00 |
Net Income Ratio | 13.79% | 13.95% | 13.68% | 13.45% | 0.00% |
EPS | 2.20 | 2.20 | 2.28 | 1.90 | 0.00 |
EPS Diluted | 2.18 | 2.16 | 2.24 | 1.87 | 0.00 |
Weighted Avg Shares Out | 33.66M | 31.90M | 29.07M | 28.49M | 28.49M |
Weighted Avg Shares Out (Dil) | 34.01M | 32.35M | 29.63M | 29.02M | 29.02M |
Source: https://incomestatements.info
Category: Stock Reports